Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 4

Current treatment options in the management of chronic prostatitis

Authors Alain Jean Duclos, Chun-Te Lee, Daniel Arthur Shoskes

Published 15 September 2007 Volume 2007:3(4) Pages 507—512

Alain Jean Duclos, Chun-Te Lee, Daniel Arthur Shoskes

Glickman Urological Institute, The Cleveland Clinic, 9500 Euclid Ave, Cleveland OH 44195, USA

Abstract: Chronic prostatitis is a disease with an unknown etiology that affects a large number of men. The optimal management for category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is unknown. The recent years have seen a significant increase in research efforts to understand, classify and treat CP/CPPS. Standard treatment usually consists of prolonged courses of antibiotics, even though well-designed clinical trials have failed to demonstrate their efficacy. Recent treatment strategies with some evidence of efficacy include: alpha-blockers, anti-inflammatory agents, hormonal manipulation, phytotherapy (quercetin, bee pollen), physiotherapy and chronic pain therapy. A stepwise, multimodal approach can be successful for the majority of patients who present with this difficult condition.

Keywords: prostatitis, chronic, treatment, management, CPPS

Download Article [PDF] 

Readers of this article also read:

Patient preferences and satisfaction in a multispecialty infusion center

Ostrov BE, Reynolds K, Scalzi LV

Patient Preference and Adherence 2014, 8:755-761

Published Date: 19 May 2014

Level of agreement between self-rated and clinician-rated instruments when measuring major depressive disorder in the Thai elderly: a 1-year assessment as part of the THAISAD study

Wongpakaran N, Wongpakaran T, Wannarit K, Saisavoey N, Pinyopornpanish M, Lueboonthavatchai P, Apisiridej N, Srichan T, Ruktrakul R, Satthapisit S, Nakawiro D, Hiranyatheb T, Temboonkiat A, Tubtimtong N, Rakkhajeekul S, Wongtanoi B, Tanchakvaranont S, Bookkamana P, Srisutasanavong U, Nivataphand R, Petchsuwan D

Clinical Interventions in Aging 2014, 9:377-382

Published Date: 25 February 2014

Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole

Hu XJ, Liu Y, Zhou XF, Zhu QL, Bei YY, You BG, Zhang CG, Chen WL, Wang ZL, Zhu AJ, Zhang XN, Fan YJ

International Journal of Nanomedicine 2013, 8:3543-3558

Published Date: 20 September 2013

High burden and unmet patient needs in chronic kidney disease

Braun L, Sood V, Hogue S, Lieberman B, Copley-Merriman C

International Journal of Nephrology and Renovascular Disease 2012, 5:151-163

Published Date: 13 December 2012

Pediatric sepsis in the developing world: challenges in defining sepsis and issues in post-discharge mortality

Wiens MO, Kumbakumba E, Kissoon N, Ansermino JM, Ndamira A, Larson CP

Clinical Epidemiology 2012, 4:319-325

Published Date: 22 November 2012

Reduced adhesion of macrophages on anodized titanium with select nanotube surface features

Rajyalakshmi A, Ercan B, Balasubramanian K, Webster TJ

International Journal of Nanomedicine 2011, 6:1765-1771

Published Date: 23 August 2011

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Jain S, Diefenbach C, Zain J, O'Connor OA

Core Evidence 2011, 6:43-57

Published Date: 4 April 2011

Doxazosin in the treatment of benign prostatic hypertrophy: an update

Timothy J Wilt, Roderick MacDonald

Clinical Interventions in Aging 2006, 1:389-401

Published Date: 15 January 2007

Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder

Bruno Aouizerate, Dominique Guehl, Emmanuel Cuny, Alain Rougier, Pierre Burbaud, Jean Tignol, Bernard Bioulac

Neuropsychiatric Disease and Treatment 2005, 1:231-243

Published Date: 15 October 2005